1033746-39-2

Upstream product

• 276884-77-6 tert-Butyl (4-formylphenoxy)acetate 
• 13518-40-6 t-butyl D-valinate hydrochloride 
• 123-08-0 4-hydroxy-benzaldehyde 
• 857506-74-2 tert-butyl N-[(benzyloxy)carbonyl]glycyl-D-valinate 
• 858104-46-8 tert-butyl (4-{(1R)-1-[(4-fluorophenyl)amino]-2-[(4-methoxybenzyl)thio]-3-oxo-3-[(4S)-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]propyl}phenoxy)acetate 
• 1033838-44-6 tert-butyl {4-[(2R,3R)-1-(4-fluorophenyl)-3-({2-[4-(methylthio)phenyl]-2-oxoethyl}thio)-4-oxoazetidin-2-yl]phenoxy}acetate 
• 858104-48-0 (3R,4R)-1-(4-fluorophenyl)-3-[(3-nitropyridin-2-yl)dithio]-4-[4-(t-butoxycarbonylmethoxy)phenyl]azetidin-2-one 
• 858104-47-9 (3R,4R)-1-(4-fluorophenyl)-3-(4-methoxybenzylsulphanyl)-4-[4-(t-butoxycarbonylmethoxy)phenyl]azetidin-2-one 
• 858104-44-6 tert-butyl (4-{[(4-fluorophenyl)imino]methyl}phenoxy)acetate 
• 858108-30-2 {4-[(2R,3R)-1-(4-fluorophenyl)-3-({2-hydroxy-2-[4-(methylthio)phenyl]ethyl}thio)-4-oxoazetidin-2-yl]phenoxy}acetic acid 
• 857506-75-3 tert-butyl glycyl-D-valinate hydrochloride 

Downstream Products

• 1033746-46-1 C₃₃H₃₄FN₃O₇S₂ 

Relevant academic research and scientific papers

DIPHENYLAZETIDINONE DERIVATES POSSESSING CHOLESTEROL ABSORPTION INHIBITORY ACTIVITY

Compounds of formula (I) (wherein variable groups are as defined within) pharmaceutically acceptable salts, solvates, solvates of such salts and prodrugs thereof and their use as cholesterol absorption inhibitors for the treatment of hyperlipidaemia are described. Processes for their manufacture and pharmaceutical compositions containing them are also described.